Response to Emergence of Middle East Respiratory Syndrome Coronavirus, Abu Dhabi, United Arab Emirates, 2013-2014

Emerg Infect Dis. 2016 Jul;22(7):1162-8. doi: 10.3201/eid2207.160040.

Abstract

In January 2013, several months after Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia, Abu Dhabi, United Arab Emirates, began surveillance for MERS-CoV. We analyzed medical chart and laboratory data collected by the Health Authority-Abu Dhabi during January 2013-May 2014. Using real-time reverse transcription PCR, we tested respiratory tract samples for MERS-CoV and identified 65 case-patients. Of these patients, 23 (35%) were asymptomatic at the time of testing, and 4 (6%) showed positive test results for >3 weeks (1 had severe symptoms and 3 had mild symptoms). We also identified 6 clusters of MERS-CoV cases. This report highlights the potential for virus shedding by mildly ill and asymptomatic case-patients. These findings will be useful for MERS-CoV management and infection prevention strategies.

Keywords: MERS-CoV; Middle East respiratory syndrome coronavirus; United Arab Emirates; asymptomatic infection; clusters; public health surveillance; respiratory disease; risk factors; viruses.

MeSH terms

  • Adult
  • Communicable Diseases, Emerging
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / virology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Middle East Respiratory Syndrome Coronavirus*
  • Retrospective Studies
  • United Arab Emirates / epidemiology
  • Young Adult